Questions To Ask
Are you currently meeting your treatment goals? There may be other appropriate options for you and your doctor to discuss. By considering important questions and reviewing relevant terms, you can help make sure you and your doctor are on the same page regarding your treatment plan.
- Moderate to SevereRheumatoid Arthritis
- ActivePsoriatic Arthritis
- Moderate to SevereUlcerative Colitis
For adults with moderate to severe rheumatoid arthritis when TNF blockers did not work well or could not be tolerated.
Some Topics For Discussion
Before your next appointment, consider the following questions and select ones to help you and your doctor discuss the risks and benefits of treatment with XELJANZ or
Speaking The Same Language
No matter where you are with your treatment, being able to clearly communicate your treatment goals, expectations—and even frustrations—is crucial to having an honest conversation with your doctor. Before your next appointment, use this glossary as a handy reference to help you and your doctor align on a treatment plan you both believe in.
Articular Cartilage
Joint Damage
Bony Ankylosis
Joint Inflammation
Synovium
Fibrous Ankylosis
Pannus
For adults with active psoriatic arthritis when TNF blockers did not work well or could not be tolerated.
Some Topics For Discussion
Before your next appointment, consider the following questions. Then select ones to help you and your doctor discuss the risks and benefits of treatment with XELJANZ or
Speaking The Same Language
No matter where you are with your treatment, being able to clearly communicate your treatment goals, expectations—and even frustrations—is crucial to having an honest conversation with your doctor. Before your next appointment, use this glossary as a handy reference to help you and your doctor align on a treatment plan you both believe in.
Articular Cartilage
Enthesitis
Joint Inflammation
Bony Ankylosis
Fibrous Ankylosis
Synovium
Dactylitis
Joint Damage
For adults with moderate to severe ulcerative colitis when TNF blockers did not work well or could not be tolerated.
Some Topics For Discussion
Before your next appointment, consider the following questions and select ones to help you and your doctor discuss the risks and benefits of treatment with XELJANZ or XELJANZ XR for your moderate to severe ulcerative colitis (UC).
Speaking The Same Language
Before you speak with your doctor, it can be helpful to review some medical terms and definitions you may need when discussing your ulcerative colitis. Use this glossary tool as a handy reference as you prepare for your next appointment.
Anemia
Colonoscopy
Gastrointestinal Bleeding
Mucosa
Remission
Bowel Urgency
Flare
Gastrointestinal Tract (GI Tract)
Rectal Bleeding
Stool Frequency
Colon
Flexible Sigmoidoscopy
Inflammation
Rectum
Tenesmus
Ulcer
Whether you want to learn more about XELJANZ or have already started on treatment, we can provide you with tools, resources, and support.
XELJANZ/XELJANZ XR (tofacitinib) is used to treat adults who have tried TNF blockers with:
- Moderately to severely active rheumatoid arthritis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or cannot be tolerated
- Active psoriatic arthritis when 1 or more tumor necrosis factor (TNF) blocker medicines have been used, and did not work well or cannot be tolerated
- Moderately to severely active ulcerative colitis when 1 or more tumor necrosis factor (TNF) blocker medicines have been used, and did not work well or cannot be tolerated
- Active ankylosing spondylitis when 1 or more tumor necrosis factor (TNF) blocker medicines have been used, and did not work well or cannot be tolerated
XELJANZ/XELJANZ Oral Solution is used to treat patients 2 years of age and older with:
- Active polyarticular course juvenile arthritis when 1 or more tumor necrosis factor (TNF) blocker medicines have been used, and did not work well or cannot be tolerated
It is not known if XELJANZ/XELJANZ XR is safe and effective in people with Hepatitis B or C.
XELJANZ/XELJANZ XR/XELJANZ Oral Solution is not recommended for people with severe liver problems.
It is not known if XELJANZ/XELJANZ Oral Solution is safe and effective in children for treatment other than active polyarticular course juvenile arthritis.
It is not known if XELJANZ XR is safe and effective in children.
XELJANZ/XELJANZ XR (tofacitinib) is used to treat adults who have tried TNF blockers with:
- Moderately to severely active rheumatoid » Read More
Indications
Important Safety Information

Pay as little as $0 per month for your XELJANZ prescription*
Eligibility required. Annual savings of $6,000–$15,000. Federal and state healthcare beneficiaries ineligible. No membership fee. Offer not valid for cash paying patients. Terms and conditions apply.

Eligibility required. Annual savings of $6,000–$15,000. Federal and state healthcare beneficiaries ineligible. No membership fee. Offer not valid for cash paying patients. Terms and conditions apply.
Sign Up